ArticleNucleic acids research2026
CpG content contributes to tissue-resident macrophage enhancer selection.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Tissue-resident macrophages acquire specialized identities through transcription factor networks operating in distinct chromatin environments. Early growth response 2 (EGR2) contributes both to alveolar macrophage identity and to interleukin (IL)-4-driven polarization of bone marrow-derived macrophages, yet the regulatory principles enabling its function across these contexts remain unclear. By integrating RNA-seq and ATAC-seq data from wild-type and Egr2-deficient macrophages, we show that macrophage identity is constrained by DNA methylation-dependent cis-regulatory landscapes. Alveolar macrophage-specific enhancers are predominantly CpG rich and hypomethylated, a feature shared with additional tissue-resident macrophage populations, whereas bone marrow-derived macrophage-accessible regulatory regions are largely CpG poor. Although IL-4 induces EGR2 together with KLF4 and DEC1 in bone marrow-derived macrophages, this transcription factor module fails to engage CpG-rich enhancers, indicating that the bone marrow-derived macrophage regulatory network lacks additional alveolar macrophage-specific components required for their activation. These findings identify CpG content as a determinant of enhancer competence and provide a mechanistic explanation for the context-dependent activity of EGR2 in macrophages, placing macrophage plasticity under the control of sequence-encoded epigenetic constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.